Insider trading

Period: 120 months Stock: STOK Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

57 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

57 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

57 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

57 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
57 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
57 decisions over 120 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

57 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
1 Nov 2024
Ticho Barry CHIEF MEDICAL OFFICER
Sold on a plan
$126.80K 10,000 at 12.68
80.1%
Sold half or more
1 Oct 2024
Ticho Barry CHIEF MEDICAL OFFICER
Sold on a plan
$120.65K 10,000 at 12.06
80.1%
Sold half or more
3 Sep 2024
Ticho Barry CHIEF MEDICAL OFFICER
Sold on a plan 2×
$149.48K 10,000 at 14.95
80.1%
Sold half or more
1 Aug 2024
Ticho Barry CHIEF MEDICAL OFFICER
Sold on a plan
$145.84K 10,000 at 14.58
80.1%
Sold half or more
2 Jul 2024
Nash Huw M. Chief Business Officer
Sold on a plan 2×
$32.78K 2,500 at 13.11
100%
Sold half or more
1 Jul 2024
Ticho Barry CHIEF MEDICAL OFFICER
Sold on a plan
$137.46K 10,000 at 13.75
80.1%
Sold half or more
3 Jun 2024
Ticho Barry CHIEF MEDICAL OFFICER
Sold on a plan 2×
$152.19K 10,000 at 15.22
80.1%
Sold half or more
20 May 2024
Nash Huw M. COO & CBO
Sold on a plan
$769.50K 50,000 at 15.39
100%
Sold half or more
20 May 2024
Sold on a plan 2×
$653.53K 42,350 at 15.43
61.1%
Sold half or more
20 May 2024
Allan Jonathan GENERAL COUNSEL & CORP SEC
Sold on a plan
$129.33K 8,599 at 15.04
76.8%
Sold half or more
1 May 2024
Ticho Barry CHIEF MEDICAL OFFICER
Sold on a plan
$113.65K 10,000 at 11.37
80.1%
Sold half or more
1 Apr 2024
Nash Huw M. COO & CBO
Sold on a plan 2×
$811.21K 61,329 at 13.23
100%
Sold half or more
1 Apr 2024
Ticho Barry CHIEF MEDICAL OFFICER
Sold on a plan
$124.68K 9,426 at 13.23
79.1%
Sold half or more
28 Mar 2024
Allan Jonathan GENERAL COUNSEL & CORP SEC
Sold on a plan 2×
$67.67K 5,126 at 13.20
66.4%
Sold half or more
1 Mar 2024
Ticho Barry CHIEF MEDICAL OFFICER
Sold on a plan
$77.47K 10,000 at 7.75
80.1%
Sold half or more
1 Feb 2024
Ticho Barry CHIEF MEDICAL OFFICER
Sold on a plan
$47.99K 10,000 at 4.80
58.9%
Sold half or more
21 Jun 2023
Allan Jonathan General Counsel & Corp Sec
Sold on a plan
$26.25K 1,948 at 13.48
100%
Sold half or more
3 Jan 2022
Nash Huw M. COO & CBO
Sold, plan not stated 3×
$87.67K 3,800 at 23.07
100%
Sold half or more
1 Dec 2021
Nash Huw M. COO & CBO
Sold, plan not stated 2×
$139.33K 5,700 at 24.44
100%
Sold half or more
3 Nov 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$47.50K 1,900 at 25.00
100%
Sold half or more
1 Nov 2021
Nash Huw M. COO & CBO
Sold, plan not stated 2×
$89.46K 3,800 at 23.54
100%
Sold half or more
1 Oct 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$141.51K 5,700 at 24.83
100%
Sold half or more
1 Sep 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$148.22K 5,700 at 26.00
100%
Sold half or more
2 Aug 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$164.55K 5,700 at 28.87
100%
Sold half or more
1 Jul 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$189.99K 5,700 at 33.33
100%
Sold half or more
1 Jun 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$22.67K 575 at 39.43
100%
Sold half or more
1 Mar 2021
LEVIN ARTHUR A Director
Sold, plan not stated 2×
$759.84K 12,500 at 60.79
100%
Sold half or more
23 Feb 2021
Sold, plan not stated
$292.99K 5,000 at 58.60
89.3%
Sold half or more
22 Feb 2021
Sold, plan not stated 3×
$1.47M 25,000 at 58.92
97.6%
Sold half or more
19 Feb 2021
TZIANABOS ARTHUR Director
Sold, plan not stated
$606.65K 10,000 at 60.67
100%
Sold half or more
6 Jan 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$1.83K 32 at 57.14
100%
Sold half or more
4 Jan 2021
Nash Huw M. COO & CBO
Sold, plan not stated 4×
$336.16K 5,700 at 58.97
99.4%
Sold half or more
18 Dec 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$480.90K 8,015 at 60.00
100%
Sold half or more
18 Dec 2020
Sold, plan not stated
$311.64K 5,194 at 60.00
100%
Sold half or more
17 Dec 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$2.52M 41,985 at 60.00
100%
Sold half or more
17 Dec 2020
Sold, plan not stated
$1.19M 19,806 at 60.00
79.2%
Sold half or more
1 Dec 2020
Nash Huw M. COO & CBO
Sold, plan not stated 4×
$284.08K 5,700 at 49.84
100%
Sold half or more
23 Nov 2020
TZIANABOS ARTHUR Director
Sold, plan not stated 4×
$920.57K 20,000 at 46.03
100%
Sold half or more
10 Nov 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$2.25M 50,000 at 45.00
100%
Sold half or more
4 Nov 2020
Sold, plan not stated 3×
$1.36M 33,268 at 40.80
98.2%
Sold half or more
3 Nov 2020
Sold, plan not stated
$69.00K 1,732 at 39.84
74.2%
Sold half or more
2 Nov 2020
Sold, plan not stated 3×
$1.30M 35,000 at 37.25
98.3%
Sold half or more
2 Nov 2020
Nash Huw M. COO & CBO
Sold, plan not stated 2×
$212.11K 5,700 at 37.21
100%
Sold half or more
19 Oct 2020
Liau Gene EVP Research & Preclinical Dev
Sold, plan not stated 2×
$1.21M 32,000 at 37.82
70.3%
Sold half or more
1 Oct 2020
Nash Huw M. COO & CBO
Sold, plan not stated 2×
$196.90K 5,700 at 34.54
100%
Sold half or more
9 Sep 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$516.03K 17,201 at 30.00
100%
Sold half or more
8 Sep 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$921.54K 30,718 at 30.00
100%
Sold half or more
1 Sep 2020
Nash Huw M. COO & CBO
Sold, plan not stated 2×
$158.11K 5,700 at 27.74
100%
Sold half or more
28 Aug 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$62.43K 2,081 at 30.00
100%
Sold half or more
3 Aug 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$140.94K 5,700 at 24.73
100%
Sold half or more
Showing 1–50 of 57. Page 1 of 2 Older →